18F-Florbetapir PET的mr引导图学习使阿尔茨海默病分期准确和可解释。

IF 4.5 2区 医学 Q1 NEUROIMAGING
Xinyi Chen, Lijuan Chen, Weiheng Yao, Qiankun Zuo, Ye Li, Dong Liang, Shuqiang Wang, Meiyun Wang, Tao Sun
{"title":"18F-Florbetapir PET的mr引导图学习使阿尔茨海默病分期准确和可解释。","authors":"Xinyi Chen, Lijuan Chen, Weiheng Yao, Qiankun Zuo, Ye Li, Dong Liang, Shuqiang Wang, Meiyun Wang, Tao Sun","doi":"10.1016/j.neuroimage.2025.121510","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Subtle structural and molecular brain changes make noninvasive early detection and staging of Alzheimer's disease (AD) challenging and critical for effective intervention. This study develops a novel graph convolutional network (GCN) learning framework that integrates amyloid-β PET imaging and MRI structural features, aiming for improved early detection and accurate staging of AD.</p><p><strong>Methods: </strong>The retrospective study utilized 18F-florbetapir PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) as the training dataset (323 scans from 196 subjects - 45 normal control, 80 mild cognitive impairment/MCI, 71 AD) and two independent datasets for testing (99 scans from 85 subjects - 31 normal control, 15 MCI, 44 AD). Individual brain graphs were constructed for each PET scan, and graph learning framework was designed to extract molecular features from PET while integrating structural features from MRI. Performance was evaluated using receiver operating characteristic (ROC) analysis, comparing results against cortical SUVR. Additionally, a biomarker GCN_score was defined based on identified salient regions-of-interest, with its effectiveness assessed using the Kruskal-Wallis test and Cohen's effect size.</p><p><strong>Results: </strong>The framework achieved AUCs of 89.8% (specificity 83.6%, sensitivity 81.6%) for distinguishing MCI from normal controls and 88.3% (specificity 81.6%, sensitivity 80.6%) for MCI from AD in the ADNI dataset, with comparable performance in external testing. All results significantly outperformed cortical SUVR (DeLong test p<0.001). The GCN_score demonstrated superior group differentiation (Cohen's effect sizes 1.744 and 1.32) compared to cortical SUVR (0.309 and 0.641).</p><p><strong>Conclusion: </strong>The proposed graph-based learning framework effectively integrates PET and MRI features for accurate AD stage distinction, showing significant promise for early detection and facilitating timely intervention.</p>","PeriodicalId":19299,"journal":{"name":"NeuroImage","volume":" ","pages":"121510"},"PeriodicalIF":4.5000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"MR-Guided Graph Learning of <sup>18</sup>F-Florbetapir PET Enables Accurate and Interpretable Alzheimer's Disease Staging.\",\"authors\":\"Xinyi Chen, Lijuan Chen, Weiheng Yao, Qiankun Zuo, Ye Li, Dong Liang, Shuqiang Wang, Meiyun Wang, Tao Sun\",\"doi\":\"10.1016/j.neuroimage.2025.121510\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Subtle structural and molecular brain changes make noninvasive early detection and staging of Alzheimer's disease (AD) challenging and critical for effective intervention. This study develops a novel graph convolutional network (GCN) learning framework that integrates amyloid-β PET imaging and MRI structural features, aiming for improved early detection and accurate staging of AD.</p><p><strong>Methods: </strong>The retrospective study utilized 18F-florbetapir PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) as the training dataset (323 scans from 196 subjects - 45 normal control, 80 mild cognitive impairment/MCI, 71 AD) and two independent datasets for testing (99 scans from 85 subjects - 31 normal control, 15 MCI, 44 AD). Individual brain graphs were constructed for each PET scan, and graph learning framework was designed to extract molecular features from PET while integrating structural features from MRI. Performance was evaluated using receiver operating characteristic (ROC) analysis, comparing results against cortical SUVR. Additionally, a biomarker GCN_score was defined based on identified salient regions-of-interest, with its effectiveness assessed using the Kruskal-Wallis test and Cohen's effect size.</p><p><strong>Results: </strong>The framework achieved AUCs of 89.8% (specificity 83.6%, sensitivity 81.6%) for distinguishing MCI from normal controls and 88.3% (specificity 81.6%, sensitivity 80.6%) for MCI from AD in the ADNI dataset, with comparable performance in external testing. All results significantly outperformed cortical SUVR (DeLong test p<0.001). The GCN_score demonstrated superior group differentiation (Cohen's effect sizes 1.744 and 1.32) compared to cortical SUVR (0.309 and 0.641).</p><p><strong>Conclusion: </strong>The proposed graph-based learning framework effectively integrates PET and MRI features for accurate AD stage distinction, showing significant promise for early detection and facilitating timely intervention.</p>\",\"PeriodicalId\":19299,\"journal\":{\"name\":\"NeuroImage\",\"volume\":\" \",\"pages\":\"121510\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NeuroImage\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.neuroimage.2025.121510\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROIMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NeuroImage","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.neuroimage.2025.121510","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的:大脑细微的结构和分子变化使得阿尔茨海默病(AD)的无创早期检测和分期具有挑战性,对有效干预至关重要。本研究开发了一种新的图卷积网络(GCN)学习框架,该框架集成了淀粉样蛋白-β PET成像和MRI结构特征,旨在提高AD的早期发现和准确分期。方法:回顾性研究使用来自阿尔茨海默病神经成像计划(ADNI)的18F-florbetapir PET扫描作为训练数据集(来自196名受试者的323次扫描- 45名正常对照组,80名轻度认知障碍/MCI, 71名AD)和两个独立数据集进行测试(来自85名受试者的99次扫描- 31名正常对照组,15名MCI, 44名AD)。为每次PET扫描构建单独的脑图,并设计图学习框架,从PET中提取分子特征,同时整合MRI的结构特征。使用受试者工作特征(ROC)分析评估表现,并将结果与皮质SUVR进行比较。此外,根据确定的显著感兴趣区域定义生物标志物GCN_score,并使用Kruskal-Wallis检验和Cohen效应量评估其有效性。结果:该框架在ADNI数据集中区分MCI与正常对照的auc为89.8%(特异性83.6%,敏感性81.6%),在AD中区分MCI的auc为88.3%(特异性81.6%,敏感性80.6%),与外部测试的性能相当。结论:所提出的基于图的学习框架有效地整合了PET和MRI特征,以准确区分AD的分期,对早期发现和及时干预具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
MR-Guided Graph Learning of 18F-Florbetapir PET Enables Accurate and Interpretable Alzheimer's Disease Staging.

Purpose: Subtle structural and molecular brain changes make noninvasive early detection and staging of Alzheimer's disease (AD) challenging and critical for effective intervention. This study develops a novel graph convolutional network (GCN) learning framework that integrates amyloid-β PET imaging and MRI structural features, aiming for improved early detection and accurate staging of AD.

Methods: The retrospective study utilized 18F-florbetapir PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) as the training dataset (323 scans from 196 subjects - 45 normal control, 80 mild cognitive impairment/MCI, 71 AD) and two independent datasets for testing (99 scans from 85 subjects - 31 normal control, 15 MCI, 44 AD). Individual brain graphs were constructed for each PET scan, and graph learning framework was designed to extract molecular features from PET while integrating structural features from MRI. Performance was evaluated using receiver operating characteristic (ROC) analysis, comparing results against cortical SUVR. Additionally, a biomarker GCN_score was defined based on identified salient regions-of-interest, with its effectiveness assessed using the Kruskal-Wallis test and Cohen's effect size.

Results: The framework achieved AUCs of 89.8% (specificity 83.6%, sensitivity 81.6%) for distinguishing MCI from normal controls and 88.3% (specificity 81.6%, sensitivity 80.6%) for MCI from AD in the ADNI dataset, with comparable performance in external testing. All results significantly outperformed cortical SUVR (DeLong test p<0.001). The GCN_score demonstrated superior group differentiation (Cohen's effect sizes 1.744 and 1.32) compared to cortical SUVR (0.309 and 0.641).

Conclusion: The proposed graph-based learning framework effectively integrates PET and MRI features for accurate AD stage distinction, showing significant promise for early detection and facilitating timely intervention.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
NeuroImage
NeuroImage 医学-核医学
CiteScore
11.30
自引率
10.50%
发文量
809
审稿时长
63 days
期刊介绍: NeuroImage, a Journal of Brain Function provides a vehicle for communicating important advances in acquiring, analyzing, and modelling neuroimaging data and in applying these techniques to the study of structure-function and brain-behavior relationships. Though the emphasis is on the macroscopic level of human brain organization, meso-and microscopic neuroimaging across all species will be considered if informative for understanding the aforementioned relationships.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信